CAS: 1454-53-1; Ethyl 1-Benzyl-4-Oxopiperidine-3-Carboxylate Hydrochloride

相似化合物

4644-61-5 98977-34-5 154548-45-5

上下游产品

CAS号109162-29-0 1-苄基六氢-4H-氮杂烷-4-醇 | CAS号3612-20-2 N-苄基-4-哌啶酮 | CAS号914612-23-0 6-苄基-4-氯-5,6,7,... | CAS号4644-61-5 4-哌啶酮-3-甲酸乙酯盐酸盐 | CAS号27296-60-2 1,2,3,4-Tetrahy... | CAS号27388-70-1 8-(1,2-Dimethyl... | CAS号27296-62-4 1,2,3,4-Tetrahy... | CAS号98977-34-5 1-N-B°C-4-氧代-3-... | CAS号79099-07-3 1-B°C-4-哌啶酮 | CAS号67848-59-3 4-氧代-3-哌啶甲酸乙酯

专利信息

专利号:US-6936600-B2
优先权日:1999-04-01
标题:Sorbitol dehrydrogenase inhibitors
发明人：CHU-MOYER MARGARET Y; MYLARI BANAVARA L; ZEMBROWSKI WILLIAM J
权利人:PFIZER
摘要:This invention is directed to sorbitol dehydrogenase inhibitory compounds of the formula I, n n nwherein R 1 , R 2 and R 3 are as defined in the specification. This invention is also directed to pharmaceutical compositions containing those compounds and methods of treating or preventing diabetic complications, particularly diabetic neuropathy, diabetic nephropathy, diabetic microangiopathy, diabetic macroangiopathy and diabetic cardiomyopathy by administering such compounds to a mammal suffering from diabetes and therefore at risk for developing such complications. This invention is also directed to pharmaceutical compositions comprising a combination of a compound of formula I of this invention with an aldose reductase inhibitor and to methods of treating or preventing diabetic complications therewith. This invention is also directed to pharmaceutical compositions comprising a combination of a compound of formula I of this invention with an NHE-1 inhibitor and to methods of treating cardiomyopathy and other heart-related problems therewith. This invention is also directed to certain intermediates used in the synthesis of the compounds of formula I and to processes for preparing those intermediates.

专利号:US-2009137557-A1
优先权日:2005-11-22
标题 :Calcilytic Compounds
发明人：KU THOMAS WEN FU; LIN HONG; LUENGO JUAN I; MARQUIS JR ROBERT W; RAMANJULU JOSHI M; TROUT ROBERT; YAMASHITA DENNIS S
权利人:KU THOMAS WEN FU; LIN HONG; LUENGO JUAN I; MARQUIS JR ROBERT W; RAMANJULU JOSHI M; TROUT ROBERT; YAMASHITA DENNIS S
摘要:Novel calcilytic compounds, pharmaceutical compositions, methods of synthesis and methods of using them are provided.